3000+ Attendees, 450 Speakers, 12 Conference Tracks, 100+ Posters
 
MMTC15_Header  
MMTC M Header 

Cambridge Healthtech Institute’s Third Annual

Companion Diagnostics

Future of Cancer Management

February 15-18, 2015 | Moscone North Convention Center | San Francisco, CA
Part of the 22nd Annual Molecular Medicine Tri-Conference

 

The field of companion diagnostics is undergoing radical changes with the battery of sequencing tests available and adoption of new clinical trial protocols. The reality is becoming apparent that a new strategy is needed for implementing and commercializing molecularly guided therapies. More personalized therapies are available but significant questions remain as to how to get patients the treatments best suited to their disease. Multi-gene panels are becoming the standard of care in oncology but the practice is far from commonplace. Practical aspects of reimbursement, regulation, patient payment responsibility, commercial launch and drug development will be covered in this comprehensive program detailing the state-of-the-art process for implementing companion diagnostics.

Who should attend: VPs, Directors, Managers, CEOs, CSOs, Professors and Scientists from Large Pharma, Biotechs and Academia working in fields of Companion Diagnostics, Business Development, R&D, Clinical Research, in vitro Diagnostics, Personalized Healthcare, Targeted Therapies and Oncology.

Topics will include, but are not limited to: 

  • Understanding newest FDA guidance for companion diagnostics, NGS and multi-gene panels
  • Reviewing newest companion diagnostic products on the market
  • Overcoming obstacles to developing companion diagnostics
  • Streamlining companion diagnostics practices for current environment and filling the pipeline
  • Analyzing impact of payment schemes, US and abroad
  • Evaluating latest companion diagnostic technologies

If you would like to submit a proposal to give a presentation at this meeting, please click here.   

The deadline for submission is July 18, 2014. 

All proposals are subject to review by the Scientific Advisory Committee to ensure the highest quality of the conference program.  Please note that due to limited speaking slots, preference is given to pharmaceutical and biotech companies, regulators and those from academia. Additionally, vendors/consultants who provide products and services to these biopharmaceutical companies are offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships. 

For more details on the conference, please contact:
Christina Lingham
Executive Director, Conferences
Cambridge Healthtech Institute
T: 781-972-5464
E: clingham@healthtech.com 

For partnering and sponsorship information, please contact:
Jon Stroup (Companies A-K)
Manager, Business Development
Cambridge Healthtech Institute
T: (+1) 781-972-5483
E: jstroup@healthtech.com 

Joseph Vacca (Companies L-Z) 
Manager, Business Development
Cambridge Healthtech Institute
T: (+1) 781.972.5431
E: jvacca@healthtech.com
 

 



Premier Sponsors:

Leica Biosystems 
 

 NanoString2   

 

Singulex 

 

Jackson Laboratory - small logo